Trade STTK stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Shattuck Labs, Inc. (STTK) is trading at US$6.50, down 3.42% today as of Oct 5, 16:00 EDT. The company has a market capitalisation of US$755.74M. Over the past 52 weeks, STTK has traded between US$1.70 and US$8.33. On Syfe you can trade STTK with $0 commission and add it to your watchlist.
| Previous close | US$6.73 |
|---|---|
| Market cap | US$755.74M |
| 52-week range | US$1.70 – US$8.33 |
| Volume | 1.24M |
| Exchange | US |
Shattuck Labs, Inc.
Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Year: 2020
Raymond James Initiates Coverage on Shattuck Labs With Strong Buy Rating, $18 Price Target
Aug 24, 11:39 AM · MT Newswires
JPMorgan Initiates Shattuck Labs at Overweight With $10 Price Target
Jul 24, 11:28 AM · MT Newswires
Shattuck Labs, Inc. (STTK) stock is trading at US$6.50, -3.42% from the previous close of US$6.73.
The market cap for Shattuck Labs, Inc. (STTK) stock is approximately US$755.74M.
The 52-week high for Shattuck Labs, Inc. (STTK) stock is US$8.33.
The 52-week low for Shattuck Labs, Inc. (STTK) stock is US$1.70.
Shattuck Labs, Inc. (STTK) does not currently pay a dividend.
Stay on top of STTK
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
